Quest Diagnostics | DGX - Ebitda


Quest Diagnostics reported $537M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Acadia Healthcare USD 173.02M 28.82M Sep/2025
Agilent USD 466M 5M Jun/2025
Baxter International USD 426M 36M Sep/2025
Bruker USD 211.6M 207.4M Dec/2025
Cardinal Health USD 981M 5M Dec/2025
Centene USD -903M 1.02B Dec/2025
Charles River Laboratories USD 258.06M 24.83M Dec/2025
Cigna USD 2.86B 56M Mar/2025
Community Health Systems USD 425M 33M Dec/2024
CVS Health USD 3.74B 349M Dec/2025
Danaher USD 2.13B 252M Dec/2025
DaVita Healthcare Partners USD 772.7M 89.45M Dec/2025
Elevance Health USD 2.19B 1.01B Sep/2025
Encompass Health USD 335.6M 35.5M Dec/2025
HCA USD 4.11B 244M Dec/2025
Henry Schein USD 291M 4M Dec/2025
Humana USD -290M 1.11B Dec/2025
Illumina USD 332M 12M Sep/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
Laboratory Of America USD 588.1M 24.1M Dec/2025
McKesson USD 1.68B 418M Sep/2025
Mettler Toledo International USD 322.64M 26.75M Sep/2025
Molina Healthcare USD 185M 265M Sep/2025
Owens Minor USD 96.6M 12.17M Jun/2025
Pediatrix Medical Group USD 49.48M 7.96M Sep/2023
Quest Diagnostics USD 537M 24M Dec/2025
Revvity USD 248.91M 48.52M Dec/2025
Tenet Healthcare USD 1.18B 84M Dec/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
UnitedHealth USD 1.5B 3.92B Dec/2025
Universal Health Services USD 670.6M 27.72M Sep/2025
Veradigm USD 38.81M 29.61M Sep/2022
Waters USD 380.97M 85.83M Dec/2025
Zoetis USD 1.04B 87M Sep/2025